Usefulness of High-Density Lipoprotein Cholesterol to Predict Survival in Pulmonary Arterial Hypertension.
It has been suggested that lipoprotein abnormalities may contribute to the pulmonary arteriolar dysfunction observed in pulmonary arterial hypertension (PAH). High-density lipoprotein cholesterol (HDL) has vasodilatory, anti-inflammatory, and endothelial protective properties. We hypothesized that a higher serum HDL level may be advantageous for survival in PAH and that the serum HDL level at diagnosis would be an independent predictor of survival in PAH and be additive to previously validated predictors of survival. This study included all patients with PAH seen at the Mayo Clinic Pulmonary Hypertension Clinic from January 1, 1995, to December 31, 2009, who had a baseline HDL measurement. Mortality was analyzed over 5 years using the Kaplan-Meier method. Univariate and multivariable Cox proportional hazards ratios were calculated to evaluate the relation between baseline HDL level and survival. HDL levels were available for 227 patients. Higher HDL levels were associated with significantly lower mortality. Patients with an HDL >54 mg/dl at diagnosis had a 5-year survival of 59%. By comparison those with an HDL <34 mg/dl had a 5-year survival of 30%. On multivariate analysis, higher HDL was associated with an age-adjusted risk ratio for death of 0.78 (CI 0.67 to 0.91; p <0.01) per 10 mg/dl increase. In conclusion, HDL was an independent predictor of survival in PAH.
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Carolyn M
CM
Larsen
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Robert B
RB
McCully
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Joseph G
JG
Murphy
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Sudhir S
SS
Kushwaha
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Robert P
RP
Frantz
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. Electronic address: kane.garvan@mayo.edu.
Garvan C
GC
Kane
D000328:Adult; D000368:Aged; D008076:Cholesterol, HDL / Q000097:blood*; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000097:blood* / Q000401:mortality; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D016016:Proportional Hazards Models; D012042:Registries; D012189:Retrospective Studies; D015996:Survival Rate; D014481:United States
D008076:Cholesterol, HDL